TNYA
Tenaya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.67
−0.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 2.15x
- P/S forward
- 24.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.17x
- Price / sales
- 112.60x
- Price / cash flow
- -2.10x
Enterprise value
- Enterprise value
- $76.2M
- EV / sales
- 57.07x
- EV / EBITDA
- -0.79x
- EV / EBIT
- -0.72x
- Market cap
- $150.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026